Literature DB >> 34107197

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply.

Haydar Frangoul1, Tony W Ho2, Selim Corbacioglu3.   

Abstract

Entities:  

Year:  2021        PMID： 34107197     DOI： 10.1056/NEJMc2103481

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

2.  Editorial: Genome Editing to Treat Cystic Fibrosis and Other Pulmonary Diseases.

Authors:  S Vaidyanathan; A L Ryan
Journal:  Front Genome Ed       Date:  2022-06-09

Review 3.  Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India.

Authors:  Kenneth Cornetta; Martín Bonamino; Johnny Mahlangu; Federico Mingozzi; Savita Rangarajan; Jayandharan Rao
Journal:  Mol Ther       Date:  2022-04-04       Impact factor: 12.910

Review 4.  Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing.

Authors:  Alexander Dimitri; Friederike Herbst; Joseph A Fraietta
Journal:  Mol Cancer       Date:  2022-03-18       Impact factor: 27.401

5.  Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.

Authors:  Lakshmanan Krishnamurti; Staci D Arnold; Ann Haight; Allistair Abraham; Gregory Mt Guilcher; Tami John; Nitya Bakshi; Shalini Shenoy; Karen Syrjala; Paul L Martin; Sonali Chaudhury; Gretchen Eames; Olusola Festus Olowoselu; Matthew Hsieh; Josu De La Fuente; Kimberly A Kasow; Elizabeth Stenger; Anne Mertens; Fuad El-Rassi; Peter Lane; Bronwen E Shaw; Lillian Meacham; David Archer
Journal:  JMIR Res Protoc       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.